Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 24 May 2027
- Last conf. stmt
- 10 May 2026
Spero Cantab UK Limited
- Incorporated
- 11 May 2016 (10 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Timothy Aaron KeutzerEsther Priya Rajavelu
- Owned by
- Spero Therapeutics, Inc.
- Accounts type
- Total exemption full
- Region
- Greater London
- Address
- 6th FloorOne London WallLondonEC2Y 5EB
Officers 2 active
Officer details are public data from the Companies House register.
Keutzer, Timothy Aaron
Director · Appointed 30 January 2026
American
Born October 1967 (59)
Rajavelu, Esther Priya
Director · Appointed 30 January 2026
American
Born June 1978 (48)
Officer history (4 former)
30 January 2026
Appointed Keutzer, Timothy Aaron as Director
30 January 2026
Appointed Rajavelu, Esther Priya as Director
30 January 2026
8 November 2019
15 April 2019
15 April 2019
11 May 2016
11 May 2016
11 May 2016
11 May 2016
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Spero Therapeutics, Inc.
Corporate entity · Notified 13 June 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. 333220858
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 October 2026 | Total exemption full accounts | 31 December 2025 | ||
| 12 August 2026 | Confirmation statement with no updates | 10 May 2026 | ||
| 11 August 2026 | Appointment of a director | |||
| 11 August 2026 | Appointment of a director | |||
| 15 July 2026 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →